DexCom Execs Sued For Allegedly Misleading Growth Claims
By Sydney Price · April 16, 2025, 8:39 PM EDT
Executives and directors of glucose monitor manufacturer DexCom Inc. have been hit with a derivative suit alleging that they concealed from investors that DexCom struggled to maintain a sales force that...
To view the full article, register now.